HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$47.46
Day range
$47.07 - $48.85
Year range
$12.58 - $51.61
Market cap
3.11B USD
Avg Volume
949.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 49.80M | 128.91% |
Net income | -46.63M | -131.95% |
Net profit margin | — | — |
Earnings per share | -0.85 | -88.89% |
EBITDA | -49.78M | -128.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 353.31M | 120.90% |
Total assets | 368.56M | 109.86% |
Total liabilities | 79.50M | 53.15% |
Total equity | 289.06M | — |
Shares outstanding | 63.32M | — |
Price to book | 9.04 | — |
Return on assets | -32.51% | — |
Return on capital | -34.36% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -46.63M | -131.95% |
Cash from operations | -36.88M | -60.56% |
Cash from investing | 38.32M | 136.12% |
Cash from financing | 739.00K | 148.82% |
Net change in cash | 2.17M | 133.67% |
Free cash flow | -19.13M | -23.30% |
About
Founded
2016
Headquarters
Website
Employees
82